[Federal Register Volume 63, Number 189 (Wednesday, September 30, 1998)]
[Notices]
[Page 52274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-26128]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices: Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting:
Name: Advisory Committee on Immunization Practices (ACIP).
Times and Dates: 8:15 a.m.-6:15 p.m., October 21, 1998. 8 a.m.-
4:30 p.m., October 22, 1998.
Place: Atlanta Marriott North Central, 2000 Century Boulevard,
N.E., Atlanta, Georgia 30345-3377.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise, the list of
vaccines for administration to vaccine-eligible children through the
Vaccines for Children (VFC) program, along with schedules regarding
the appropriate periodicity, dosage, and contraindications
applicable to the vaccines.
Matters to be Discussed: The agenda will include an update on
the Food and Drug Administration; National Immunization Program;
update on the Vaccine Injury Compensation Program; update on the
National Vaccine Program; review of changes in the revised draft
rabies recommendation; consider for approval or modification the
draft recommendations for use of Lyme disease vaccine; progress on
The Guide to Community Preventive Services chapter on methods to
raise vaccination coverage levels among children, adolescents, and
adults; approval of changes in the harmonized immunization schedule;
approval of the Notice to Readers for hepatitis B and for DTaP;
consolidate resolutions currently included in the Vaccines for
Children (VFC) Program; resolution to include rotavirus in the VFC
Program; discuss the present ACIP general recommendations;
computerization of ACIP recommendations; pneumococcal conjugate
vaccine; update on U.S. influenza activity; update on ACIP
prevention and control guidelines; influenza outbreak aboard a
cruise ship in 1997; influenza outbreak among tour group passengers
in Alaska in 1998; 1997-98 Aviron live attenuated influenza vaccine
trial; 1997-98 vaccine cost effectiveness study of healthy adult
workers; update on implementation of the sequential IPV/OPV
schedule; revised recommendation for vaccination of children against
hepatitis A; and the Infectious Disease Society of America efforts
on vaccine safety. Other matters of relevance among the Committee's
objectives may be discussed.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Gloria A. Kovach, Committee
Management Specialist, CDC, 1600 Clifton Road, NE, Mailstop D50,
Atlanta, Georgia 30333, telephone 404/639-7250.
Dated: Setember 24, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 98-26128 Filed 9-29-98; 8:45 am]
BILLING CODE 4163-18-P
